WORLDCOM AWARD 2024 in Tokyo Held on Jun 5, 2024
13.6.2024 13:00:00 EEST | Business Wire | Press release
WORLDCOM Public Relations Group held its inaugural "WORLDCOM AWARD 2024 in Tokyo" ceremony in Tokyo, recognizing companies that should be highlighted globally from Japan. The event was organized by AZ WORLDCOM JAPAN Co., Ltd., a member of the WORLDCOM Public Relations Group since 1992. The award ceremony took place on June 5, with representatives from eight distinguished companies receiving accolades from WORLDCOM Public Relations Group's representatives and key executives. Following the ceremony, a reception was held, attended by over 100 participants from 28 countries, celebrating the achievements in grand style.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240609539044/en/
WORLDCOM AWARD 2024 - Ceremony (Photo: Business Wire)
"Each of these companies is truly outstanding and deserves to be showcased to the world. We hope this recognition will further contribute to their continued prosperity." said Stefan Pollack, chairman of the WORLDCOM Public Relations Group and president of the Pollack Group.
“WORLDCOM AWARD 2024 in Tokyo” - Winners
-
Arcuss Japan Inc.
President and CEO: Nobuaki Matsubara
https://www.arcuss-japan.com/ -
HT INTERNATIONAL
President and CEO: Takenori Yamamura
https://www.hti-trade.com/ -
SAKURA Co.,Ltd.
CEO: Kazuyoshi Takahashi
https://www.sakura2012.co.jp/ -
NALU Co.,Ltd.
President and CEO: Tomoko Hori
https://nalu-japan.com/ -
Holon System Co.,Ltd
Chairman: Masahiro Kobayashi
https://www.holon.co.jp/ -
Yokobiki Shutter Co.,Ltd.
CEO: Shinjiro Ichikawa
https://www.yokobiki-shutter.co.jp/ -
Manyou Kensetsu
CEO: Shunichi Sasaki
https://man-you.jp/ -
GATES Inc.
CEO: Yuji Sekino
https://gatestokyo.co.jp/
About the WORLDCOM Public Relations Group
The WORLDCOM Public Relations Group is the world’s leading partnership of independently owned public relations firms, with 143 offices employing some 2,000 staff in 115 cities across six continents. In total, WORLDCOM partners reported combined revenue of US$350+ million last year from 3,034 clients. Established in 1988, the group was formed so that the strongest, most capable independent firms could deliver immediate impact and sustained value through the intelligent use of communications – wherever in the world a client needs support. Partners serve national, international, and multinational clients.
About AZ WORLDCOM Japan Co., Ltd.
AZ WORLDCOM JAPAN Co., Ltd. was founded in 1989, based in Tokyo, Japan, and provides a wide range of PR consulting services for both B2B and B2C clients domestically and internationally. The company has been a member of the WORLDCOM Public Relations Group for over 30 years, contributing significantly to the group's global PR initiatives.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240609539044/en/
Contacts
AZ WORLDCOM JAPAN Co., Ltd.
TEL: +81-3-5005-0281
E-mail: info@azw.co.jp
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NIQ’s Optiq™ Goes Live in Discover, Expanding Access to Trusted Consumer Intelligence9.9.2026 13:45:00 EEST | Press release
NielsenIQ (NIQ), a leading consumer intelligence company, today announced that Optiq is now live within Discover, NIQ’s platform for accessing, analyzing and applying consumer and market intelligence, advancing the company’s strategy to make trusted consumer intelligence easier to access and apply. Where Ask Arthur introduced new ways to explore and analyze NIQ data through AI within Discover, Optiq expands that experience across conversational AI, mobile access and enterprise AI integrations, giving clients greater flexibility to access and apply NIQ intelligence across the applications and workflows where they make decisions. “AI models are becoming ubiquitous. Trusted intelligence is not,” said Irina Stoian, Chief AI Commercial Officer at NIQ. “That is why we are building the full system. Think of it like a body: harmonized NIQ data acts as the nervous system, delivering signals about the marketplace to decisioning agents that act as the brain, helping clients evaluate relevant info
Cegid and Silae Join Forces to Create a European Leader in AI-Driven Business Technology9.9.2026 13:32:00 EEST | Press release
Cegid, an AI-driven European leader in cloud business management software for small and medium-sized businesses (SMBs), and accounting professionals, and Silae, France’s leading payroll and human resources platform, today announced their intention to merge. The combination will create a national technology champion and the leading European technology platform for businesses and their partners, helping them grow safely and efficiently with the support of a fully integrated and compliant suite covering their end-to-end financial and administrative needs. Between them, Cegid, following its recent acquisition of Shine, and Silae power the day-to-day accounting, tax, finance and payroll of 2 million end-customers and more than 15,000 chartered accountancy firms, while producing more than 13 million payslips across Europe every month. The planned transaction is expected to value the combined group at more than €10 billion in enterprise value, positioning it as one of France's largest softwar
Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year9.9.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today the topline 52-week results (Part C) from its Phase 3 COMP005 trial of COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD) which further support COMP360’s differentiated profile and potential for long lasting benefit. The open-label Part C data demonstrate four important findings: first, notable additional benefit was observed with an added reduction in MADRSscore leading to an average 13-point reduction from baseline at Week 52 and extended out to 1 year for participants who were randomized to the 25 mg arm and received an additional dosein Part C; second, for participants in the Placebo arm who received their first dose of COMP360 25 mg in Part C, these findings further reinforce that a single dose of 25 mg has the potential to produce rapid onset, meaningful effect and durabi
New ABB and BCG Report Highlights Growing Role of Direct Current Technologies in Future Power Systems9.9.2026 12:42:00 EEST | Press release
ABB today published a new report, The Strategic Case for Hybrid AC/DC Power: Shaping the Transition to the Next Electrical Architecture, developed in collaboration with Boston Consulting Group (BCG). The report makes the case that direct current (DC) technology is moving from the periphery to the center of industrial, commercial, and digital infrastructure – and that the decisions made by business leaders and policymakers in the next two to three years will determine who shapes that transition and who inherits it. The future of power distribution is not an either-or choice between alternating current (AC) and direct current, but a hybrid system that combines the strengths of both technologies. While AC will remain the backbone of most transmission and regional distribution networks, DC is expected to play an increasingly important role within facilities where many major energy sources and loads already operate natively on direct current. The fastest-growing technologies, including sola
Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities9.9.2026 12:00:00 EEST | Press release
Chiesi Group ("Chiesi"), an international research-focused biopharmaceutical company and certified B Corp, today announced its financial results for the six months ended 30 June 2026 ("H1 2026"). Performance across therapeutic areas and regions Chiesi reported revenues of €1.89 billion, representing growth of +3.6% at constant exchange rates (CER) compared with H1 2025. These results do not include the impact of the recent acquisition of KalVista Pharmaceuticals. The Group's growth is supported by continued expansion of its global rare diseases area (+€45m; +9.9% @CER), and sustained performance in neonatology and specialty care therapeutic areas (+6.5% @CER). The respiratory health area remains broadly stable (-0.8% @CER) fueled by the strong growth in our inhaled triple therapy portfolio. Driven by the ongoing execution of its international growth strategy, Chiesi continued to expand its presence in key markets, with particularly strong momentum in the United States (+9.6% @CER), whi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom